Cargando…
Plasma P‐selectin is an early marker of thromboembolism in COVID‐19
Autores principales: | Fenyves, Bánk G., Mehta, Arnav, Kays, Kyle R., Beakes, Caroline, Margolin, Justin, Goldberg, Marcia B., Hacohen, Nir, Filbin, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616847/ https://www.ncbi.nlm.nih.gov/pubmed/34622480 http://dx.doi.org/10.1002/ajh.26372 |
Ejemplares similares
-
Plasma P-selectin is an early marker of thromboembolism in COVID-19
por: Fenyves, Bánk G., et al.
Publicado: (2021) -
Plasma P-selectin is an early marker of thromboembolism in COVID-19
por: Mehta, Arnav, et al.
Publicado: (2023) -
Reply to Akin et al.: High Renin Concentrations in Severe COVID-19 Are Indicative for a Hypo–Renin–Angiotensin-System State
por: Leisman, Daniel E., et al.
Publicado: (2022) -
Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study
por: Leisman, Daniel E., et al.
Publicado: (2021) -
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
por: Reyes, Miguel, et al.
Publicado: (2021)